Xinyu Wan

发表

Identification of functional cooperative mutations of GNAO1 in human acute lymphoblastic leukemia.

Lixia Ding, Lili Song, Yi Yang, 2020, Blood.

Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

J. Chen, F. Xue, Q. Xia, 2021, Cell transplantation.

Successful Treatment of TCF3-HLF-positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy.

Lixia Ding, Tianyi Wang, Xinyu Wan, 2021, Clinical lymphoma, myeloma & leukemia.

Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary Relapse

Lixia Ding, Lili Song, J. Chen, 2021, Cancer research and treatment.

A novel nomogram containing efficacy indicators to predict axillary pathologic complete response after neoadjuvant systemic therapy in breast cancer

Xinyu Wan, X. Zha, Wenjie Shi, 2022, Frontiers in Endocrinology.

Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II Trial

Cheng Cheng, C. Pui, Lixia Ding, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer.

Ye Wang, Xinyu Wan, Lexin Wang, 2023, Nanomedicine : nanotechnology, biology, and medicine.

Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete response

Xinyu Wan, Wenjie Shi, Lu Xu, 2023, Frontiers in Oncology.

Comparison of clinicopathological characteristics and response to neoadjuvant systemic therapy in patients with HER2-low-positive and HER2-zero breast cancer

Xinyu Wan, Wenjie Shi, Lu Xu, 2023, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

Prognostic analysis of three forms of Ki‐67 in patients with breast cancer with non‐pathological complete response before and after neoadjuvant systemic treatment

Xinyu Wan, Wenjie Shi, Jue Wang, 2023, Cancer medicine.

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy

Lixia Ding, Lili Song, Xiang Wang, 2023, Journal of Translational Medicine.

Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis

Xinyu Wan, X. Zha, Wenjie Shi, 2022, Breast.

Efficacy comparisons of solvent-based paclitaxel, liposomal paclitaxel, nanoparticle albumin-bound paclitaxel, and docetaxel after neoadjuvant systemic treatment in breast cancer.

Xinyu Wan, Lu Xu, Jue Wang, 2023, Nanomedicine : nanotechnology, biology, and medicine.